Browse investing articles and stock analysis by Jake Lerch. Get expert financial insights and investment advice from The Motley Fool.

Full-year 2025 guidance: non-GAAP operating margin -- Expected between 23.5% and 24.5%, reflecting increases in sales and ...

Strategic acquisition -- Grupo Aeroportuario del Sureste ( ASR +1.31%) entered a definitive agreement to acquire URW Airports for an enterprise value of $295 million, providing entry into high-traffic ...

BradyScan App Launch -- Announced as available on Android and Apple, supporting barcode generation, scanning, security ...

Join us as we dissect Lululemon's stock performance and explore whether it can reclaim its former glory in the competitive ...

Zisapel explained that the current demand environment is "solid" and not meaningfully changed from the prior quarter, while ...

Upcoming product launches -- AMP-007 inhalation on track for mid-2026 launch targeting a $1.5 billion market; generic ...

Q4 2025 guidance -- Projected total revenue of $371 million to $377 million; subscription revenue of $258 million to $261 ...

One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.

Both of these electric air taxi pioneers have sold off hard recently, creating a potential entry point for patient investors.

A brutal 90% single-day crash and a shareholder’s full exit raise the stakes for MoonLake’s upcoming FDA meeting.

One fast-rising biotech is gearing up for pivotal trials just as a major specialist fund walks away—here’s what long-term ...